Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05495971 · ClinicalTrials.gov registry record · NA
Extended Depth of Focus Contact Lenses for Presbyopia
A NA study, sponsored by Visioneering Technologies.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT05495971: Completed NA study, sponsored by Visioneering Technologies.
NCT05495971 is a NA study that has completed, run by Visioneering Technologies. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05495971, a NA study, has completed, sponsored by Visioneering Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.
Primary Outcome
High contrast/high illumination distant (6M) logMAR vision
Interventions
- DEVICE NaturalVue Multifocal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2023-05-12 |
| Phase | NA |
What the finished NCT05495971 record still lists
NCT05495971 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which NaturalVue Multifocal is the first listed.
NCT05495971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05495971 about?
NCT05495971 is a clinical study titled "Extended Depth of Focus Contact Lenses for Presbyopia". VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.
What is the current status of trial NCT05495971?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2022-09-06. Estimated completion is 2023-05-12.
What interventions are being tested in trial NCT05495971?
The interventions under investigation include: NaturalVue Multifocal (DEVICE).
Who is sponsoring clinical trial NCT05495971?
This trial is sponsored by Visioneering Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05495971's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI